SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-053546
Filing Date
2020-11-12
Accepted
2020-11-12 16:06:06
Documents
64
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q idya-10q_20200930.htm 10-Q 2769928
2 EX-10.1 idya-ex101_656.htm EX-10.1 79986
3 EX-31.1 idya-ex311_8.htm EX-31.1 18188
4 EX-31.2 idya-ex312_6.htm EX-31.2 18245
5 EX-32.1 idya-ex321_9.htm EX-32.1 12419
  Complete submission text file 0001564590-20-053546.txt   7827466

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT idya-20200930.xml EX-101.INS 1398983
7 XBRL TAXONOMY EXTENSION SCHEMA idya-20200930.xsd EX-101.SCH 54455
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE idya-20200930_cal.xml EX-101.CAL 46871
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE idya-20200930_def.xml EX-101.DEF 189820
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE idya-20200930_lab.xml EX-101.LAB 442641
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idya-20200930_pre.xml EX-101.PRE 329351
Mailing Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-443-6209
IDEAYA Biosciences, Inc. (Filer) CIK: 0001676725 (see all company filings)

IRS No.: 474268251 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38915 | Film No.: 201306616
SIC: 2834 Pharmaceutical Preparations